Listed equity
Natco Pharma
पिरामल एंटर · પિરામલ એંટર.
₹1110.00▲₹0.00(+0.00%)
EOD close · 22 Sept 2025
breakdowndistribution -34
Both signals point the same way: the trend is weak (18% off its 52-week high) and delivery buyers are absent. Sellers are in control.
52W low ₹849.9052W high ₹1355.90
Now at 51% of its 52-week range
Long-term returns
1Y
+4.8%
3Y
+17.9%
5Y
-9.1%
10Y
+34.5%
Phase indicator
breakdown-18.1% from 52w high
Below 200-day MA — long-term trend negative.
1M
-3.7%
3M
+0.4%
1Y
+4.8%
Delivery conviction
distributionscore -34
Delivery vs 20-day avg0.58x
Lifetime story
Natco Pharma is up 2623.3% from its lifetime low of ₹40.76 on 31 Mar 2003. ₹10,000 invested then would be worth ₹2,72,326 today (15.8% CAGR over 22.5 years). Lifetime high of ₹3302.55 was set on 31 Aug 2018 (currently -66.4% below).
Fundamentals
Standalone vs consolidated — most retail products show only one. Consolidated includes subsidiary contribution.
131% premium to industry(Industry P/E 25.2)
| Standalone | Consolidated | |
|---|---|---|
| P/E (TTM)subs material | 58.18 | 43.93 |
| P/B | 1.16 | 0.94 |
| Price / Cash flowsubs material | 55.89 | 32.10 |
| Dividend yield | 0.98% | 0.98% |
| Book value / sharesubs material | 969.14 ₹ | 1195.36 ₹ |
| EPS (TTM)subs material | 19.33 ₹ | 25.60 ₹ |
Market cap
₹25.5K Cr
52W high
₹1355.90
30 Jul 2025
52W low
₹849.90
3 Mar 2025
Returns ladder
1W
-1.7%
1M
-3.7%
3M
+0.4%
6M
+12.8%
YTD
+1.9%
1Y
+4.8%
3Y
+17.9%
5Y
-9.1%
10Y
+34.5%
Since listing
+599.6%